Clinical Trials in Arizona

Showing 12141-12160 of 16,770 trials

COMPLETEDPhase 131 miles

BAY80-6946 Open Label, Phase I Study in Patients With Advanced Cancer

NCT00962611

The purpose of this study is to determine the tolerability, maximum tolerated dose and pharmacokinetics of this drug.

Neoplasms

Bayer57 participantsStarted Nov 2009

Scottsdale, Arizona, United States • Pittsburgh, Pennsylvania, United States • San Antonio, Texas, United States

COMPLETEDPhase 1/231 miles

Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT00935792

RATIONALE: Everolimus may stop the growth of cancer cells by blocking some of the signaling molecules needed for cell growth. Monoclonal antibodies, such as alemtuzumab, can bind to and kill malignant lymphocytes. PURPOSE: This phase I/II trial is studying the side effects and best dose of everolimus when given together with alemtuzumab and will see how well they work in treating patients with recurrent chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL).

Lymphocytic Leukemia

Mayo Clinic28 participantsStarted Jul 2009

Scottsdale, Arizona, United States • Rochester, Minnesota, United States

COMPLETED33 miles

Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture

NCT02719769

The "Evaluation of Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture Identification \& Antimicrobial Susceptibility Testing" is designed to validate the clinical performance of the Accelerate ID/AST System for positive blood culture identification and susceptibility testing in a clinical setting. The data from this study will be used to support the 510(k) submission for FDA clearance and global registrations of the device intended for in vitro diagnostic use.

BacteremiaFungemia

Accelerate Diagnostics, Inc.4,009 participantsStarted Jan 2016

Gilbert, Arizona, United States • Tucson, Arizona, United States • Los Angeles, California, United States +11 more locations

BAY80-6946 Open Label, Phase I Study in Patients With Advanced Cancer

Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture

Find Trials by Condition in Arizona

Study of AA4500 in the Treatment of Peyronie's Disease

AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder

Aquacel Versus Iodoform Gauze for Filling Abscess Cavity Following Incision and Drainage

Time to Eugonadal Range, Time to Steady State and Drying Time

Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer

Study of Efficacy, Safety of Fulranumab Adjunctive Use in OA of Hip or Knee, PAI3001

Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Inhaled Nitric Oxide Study for Respiratory Failure in Newborns

MSC2364447C Phase 1b in Systemic Lupus Erythematosus

Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily

Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure

A Study to Evaluate Efficacy and Safety of ADC3680 in Subjects With Inadequately-Controlled Asthma

Memantine and Cognitive Dysfunction in Bipolar Disorder

Safety and Efficacy of a Contraceptive Vaginal Ring Delivering Nestorone® and Ethinyl Estradiol

N2007-01: Ultratrace™ Iobenguane I 131 in Patients With Relapsed/Refractory High-Risk Neuroblastoma

Clinical Trials to Reduce the Risk of Antimicrobial Resistance

Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation